These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Immune-mediated neuropathies: indications and value of nerve biopsy]. Verschueren A Rev Neurol (Paris); 2007 Sep; 163 Spec No 1():3S58-60. PubMed ID: 18087231 [TBL] [Abstract][Full Text] [Related]
6. Clinical and electrophysiologic correlates of IVIg responsiveness in CIDP. Iijima M; Yamamoto M; Hirayama M; Tanaka F; Katsuno M; Mori K; Koike H; Hattori N; Arimura K; Nakagawa M; Yoshikawa H; Hayasaka K; Onodera O; Baba M; Yasuda H; Saito T; Nakazato M; Nakashima K; Kira J; Kaji R; Oka N; Sobue G Neurology; 2005 Apr; 64(8):1471-5. PubMed ID: 15851750 [TBL] [Abstract][Full Text] [Related]
10. Criteria for demyelination based on the maximum slowing due to axonal degeneration, determined after warming in water at 37 degrees C: diagnostic yield in chronic inflammatory demyelinating polyneuropathy. Van Asseldonk JT; Van den Berg LH; Kalmijn S; Wokke JH; Franssen H Brain; 2005 Apr; 128(Pt 4):880-91. PubMed ID: 15689367 [TBL] [Abstract][Full Text] [Related]
11. Threshold electrotonus in chronic inflammatory demyelinating polyneuropathy: correlation with clinical profiles. Sung JY; Kuwabara S; Kaji R; Ogawara K; Mori M; Kanai K; Nodera H; Hattori T; Bostock H Muscle Nerve; 2004 Jan; 29(1):28-37. PubMed ID: 14694495 [TBL] [Abstract][Full Text] [Related]
13. Macrophage clustering as a diagnostic marker in sural nerve biopsies of patients with CIDP. Sommer C; Koch S; Lammens M; Gabreels-Festen A; Stoll G; Toyka KV Neurology; 2005 Dec; 65(12):1924-9. PubMed ID: 16380614 [TBL] [Abstract][Full Text] [Related]
14. Onset and course of chronic inflammatory demyelinating polyneuropathy. Mygland A; Monstad P; Vedeler C Muscle Nerve; 2005 May; 31(5):589-93. PubMed ID: 15742374 [TBL] [Abstract][Full Text] [Related]
15. Antibody- and macrophage-mediated segmental demyelination in chronic inflammatory demyelinating polyneuropathy: clinical, electrophysiological, immunological and pathological correlates. Vallat JM; Mathis S; Vegezzi E; Richard L; Duchesne M; Gallouedec G; Corcia P; Magy L; Uncini A; Devaux J Eur J Neurol; 2020 Apr; 27(4):692-701. PubMed ID: 31769579 [TBL] [Abstract][Full Text] [Related]
16. Does the chronic inflammatory demyelinating polyradiculoneuropathy due to secondary cause differ from primary? Wadwekar V; Kalita J; Misra UK Neurol India; 2011; 59(5):664-8. PubMed ID: 22019647 [TBL] [Abstract][Full Text] [Related]
17. Electrodiagnostic criteria in CIDP: comparison with diabetic neuropathy. Wilson JR; Park Y; Fisher MA Electromyogr Clin Neurophysiol; 2000; 40(3):181-5. PubMed ID: 10812541 [TBL] [Abstract][Full Text] [Related]
18. Polyneuropathies in teenagers: a clinicopathological study of 45 cases. Kararizou E; Karandreas N; Davaki P; Davou R; Vassilopoulos D Neuromuscul Disord; 2006 May; 16(5):304-7. PubMed ID: 16616844 [TBL] [Abstract][Full Text] [Related]
19. Chronic dysimmune neuropathy. A subclassification based upon the clinical features of 102 patients. Busby M; Donaghy M J Neurol; 2003 Jun; 250(6):714-24. PubMed ID: 12796835 [TBL] [Abstract][Full Text] [Related]
20. Chronic inflammatory demyelinating polyradiculoneuropathy in children: characterized by subacute, predominantly motor dominant polyeuropathy with a favorable response to the treatment. Jo HY; Park MG; Kim DS; Nam SO; Park KH Acta Neurol Scand; 2010 May; 121(5):342-7. PubMed ID: 20003085 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]